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ABSTRACT
ATM (ataxia-telangiectasia mutated) is a central
molecule for DNA quality control. Its activation by
DNA damage promotes cell-cycle delay, which facil-
itates DNA repair prior to replication. On the other
hand, persistent DNA damage has been implicated
in ATM-dependent cell death via apoptosis; however,
the mechanisms underlying this process remain elu-
sive. Here we find that, in response to persistent
DNA strand breaks, ATM phosphorylates transcrip-
tion factor Sp1 and initiates its degradation. We show
that Sp1 controls expression of the key base exci-
sion repair gene XRCC1, essential for DNA strand
break repair. Therefore, degradation of Sp1 leads to
a vicious cycle that involves suppression of DNA
repair and further aggravation of the load of DNA
damage. This activates transcription of pro-apoptotic
genes and renders cells susceptible to elimination
via both apoptosis and natural killer cells. These
findings constitute a previously unrecognized ‘gate-
keeper’ function of ATM as a detector of cells with
persistent DNA damage.
INTRODUCTION
Failure to preserve genome stability underlies the decline of
every organism through pathophysiological processes such
as ageing, neurodegeneration and cancer. For this reason,
the cellular genome is constantly guarded against DNA le-
sions generated by both exogenous and endogenous muta-
gens. In order to maintain genome stability, cells exploit a
number of DNA repair systems. Amongst these, the DNA
base excision repair (BER) pathway constitutes the front-
line defense against endogenously-generated DNA damage
includingDNAbase lesions and single strand breaks (SSBs)
(1,2). BER is robust pathway that, under normal circum-
stances, is sufficient to copewith endogenousDNAdamage.
However, low BER efficiency can occur as a result of mal-
function of BER components or overload of cellular repair
capacity by acute DNA damage. This can either lead to cell
death, or result in accumulation of mutations and induc-
tion of tumorigenesis (3–5). It is still poorly understood how
cells decide to trigger apoptosis and eliminate potentially
dangerous cells, rather than attempting DNA repair of ex-
cessively damaged DNA. The ATM (ataxia-telangiectasia
mutated) protein is the primary candidate for this role of
decision maker (6). In fact, ATM’s kinase activity has been
shown to respond to a wide range of genome-threatening le-
sions including DNA single and double strand breaks (7,8)
and to mobilize a cascade of phosphorylation events that
delay cell cycle, providing additional time for DNA repair
prior to replication (9). At the same time, ATM has been
implicated in the initiation of programmed cell death in
response to DNA damage (10,11). Despite this, although
ATM-dependent cell cycle delay is known to be mainly ac-
complished through effectors such as p53 and p21 (12), the
mechanisms driving an ATM-dependent switch to apopto-
sis are unclear.
Among a number of proteins that are phosphorylated by
ATM in response toDNAdamage, transcription factor Sp1
has been shown to regulate the expression of multiple genes
(13–15), including cellular components involved in apopto-
sis (16–18). While ATM-dependent phosphorylation of Sp1
at serine 101 has been previously documented (13–15), the
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biological role of thismodification remains unclear.Herewe
report that, in response to persistent DNA strand breaks,
ATMphosphorylates transcription factor Sp1 at serine 101,
initiating its proteasomal-dependent degradation. We also
find that Sp1 controls the expression of the key BER gene
XRCC1 and that degradation of Sp1 decreases DNA re-
pair capacity and aggravates the load of DNA damage.
This feeds a vicious cycle that further supports Sp1 degra-
dation. Furthermore, we demonstrate that downregulation
of Sp1 upon DNA damage primes fibroblasts to apopto-
sis and to elimination by natural killer (NK) cells. We sug-
gest that this mechanism allows the detection of potentially
pre-cancerous cells bearing persistent DNA strand breaks,
prompting their removal either through apoptosis or via the
innate immune system.
MATERIALS AND METHODS
Cell culture and drug treatments
Normal human TIG-1 fibroblasts were from the Coriell
Institute Cell Repository (AG06173). Cells were cultured
in Dulbecco’s modified Eagle’s medium low glucose (Life
Technologies) supplemented with 15% foetal bovine serum
(FBS) at 37◦C in a humidified atmosphere with 5% CO2.
The Nishi NK cell line has been previously described, and
is derived from the peripheral blood mononuclear cells
of a boy with chronic active Epstein–Barr virus infection
complicated with NK leukaemia. The phenotype of this
NK leukaemia is: CD94 /NKG2A and LIR-1 / ILT-2 pos-
itive, but CD3, TCR,  TCR, KIR3DL1, KIR2DL1,
KIR2DL2, KIR2DS1, KIR2DS2 negative. CD16 expres-
sion is low (19). NK cells were grown in IMDM Glu-
taMAX™ medium (Life Technologies) supplemented with
10% FBS, 2% heat-inactivated human serum (Sigma-
Aldrich), 100 IU/ml penicillin, 100 g/ml streptomycin
and 10 ng/ml recombinant human IL-15 (PeproTech) at
37◦C in a humidified atmosphere with 7.5% CO2. Cells
were routinely checked for mycoplasma. H2O2, camp-
tothecin, cycloheximide, the Chk1 inhibitor (UCN-01) and
midostaurin were from Sigma. Zeocin was from Life Tech-
nologies. Mithramycin A and MG132 were from Enzo Life
Sciences. The ATM inhibitors (KU55933 and KU60019),
the DNA-PK inhibitor (Inhibitor III) and staurosporine
were obtained from Millipore, while the Chk2 inhibitor
(CCT 241533) was from Tocris. The ataxia telangiectasia
and Rad3-related (ATR) inhibitor (VE-821) was a kind gift
fromDrAndersonRyan (University ofOxford). Navitoclax
(ABT-263) was purchased from Cayman Chemical.
Cell viability assays
Cell viability was assessed using resazurin (Sigma). For co-
culture experiments, TIG-1 cells were treated as described
and a suspension of NK cells was aliquoted onto adherent
fibroblasts at the indicated NK:TIG-1 ratio. Cell cytotoxic-
ity was assessed after co-incubation bywashing off NK cells
and evaluating the viability of fibroblasts using a resazurin
assay.
Comet assays, immunostaining and high-throughput mi-
croscopy
Alkaline comet assays were carried out as previously
described (7). Immunostaining and high-throughput mi-
croscopy were carried out as described in (20).
Protein expression and purification
The plasmid pN3-Sp1FL, containing full-length Sp1 was
a gift from Guntram Suske (Addgene plasmid #24543). A
pET-28a plasmid expressingHis(6)-tagged recombinant Sp1
was generated by sub-cloning the Sp1 cDNA from pN3-
Sp1FL. Protein expression was carried out in Rosetta™ Es-
cherichia coli cells and recombinant Sp1 was purified under
denaturing conditions (6 M guanidine hydrochloride) us-
ing a HisTrap column (GE Healthcare). Recombinant Sp1
was refolded over 96 h by sequential dialysis against 10 mM
Tris–HCl, pH 7.5, 200 mM NaCl, 50 M ZnSO4, 0.4 M
L-Arginine, 5% glycerol for 48 h, followed by 10 mM Tris–
HCl, pH 7.5, 200 mM NaCl, 5% glycerol for further 48 h.
In vitro phosphorylation assays
Phosphorylation reactions were carried out by combining
recombinant Sp1 (500 ng) and active recombinant ATM
(100 ng - Millipore) in phosphorylation buffer (50 mM
HEPES pH 7.5, 50 mM KCl, 10 mM MgCl2, 10 mM
MnCl2, 1 mM adenosine triphosphate (ATP), 1 mMdithio-
threitol (DTT) and 5% glycerol). Reactions were incubated
for 2 h at 30◦C and halted by adding sodium dodecyl
sulphate-polyacrylamide gel electrophoresis loading buffer.
In vitro ligation assays
Nuclear cell extracts were prepared as described previously
(21). Ligation assays were carried out using 1 g of nuclear
extract essentially as described in (22), with minor modifi-
cations. Briefly, reactions were performed in 50 mM Tris–
HCl pH 7.5, 10 mM MgCl2, 10 mM DTT, 1 mM ATP at
23◦C for the indicated time; the oligonucleotide substrate
(50 nM) has been described (22) and was 5′-labeled with
IRDye®800 (IDT). Reactions were halted with 96% for-
mamide and 10mMEDTAand analysed by electrophoresis
on a 20% denaturing polyacrylamide gel. The percentage of
substrate converted to product was determined by using an
Odyssey image analysis system (Li-Cor Biosciences).
Luciferase assays and chromatin immuno-precipitation
(ChIP)
Luciferase assays and chromatin immuno-precipitation
(ChIP) assays were carried out essentially as in (20). Sp1
binding to the XRCC1 promoter (−196 to −17 bp) was
assessed by ChIP using the primers reported in the Sup-
plementary Methods. For luciferase assay, a reporter plas-
mid containing the XRCC1 promoter was generated by
amplifying the genomic region upstream the XRCC1 gene
(−3969 to +174 bp) and by cloning it into a pGL3 plasmid
(Promega) using standard molecular biology techniques.
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Figure 1. ATM is the main kinase responsible for serine 101 phosphorylation of Sp1. (A and B) Representative in vitro kinase assay using recombinant
ATM (rATM) and wild-type (WT) or Ser101-Ala mutant (S101A) recombinant Sp1 proteins (rSp1). ATM can phosphorylate WT Sp1 but is unable to
phosphorylate the S101A mutant. Reactions were probed with either the phosphorylated Ser101-specific antibody (A) or an ATM/ATR substrate-specific
pS/pT QG antibody (B). (C) Representative Western blot analysis on TIG-1 cells showing Sp1 phosphorylation at Ser101 upon H2O2 treatment (200 M,
1 h). Loss of phosphorylation occurs in the presence of ATM inhibitor (ATMi: KU55933, 10 M, 2 h prior to H2O2). (D) Representative Western blot
analysis as in (C), in the presence of Chk1 inhibitor (UCN-01, 10 M for 2 h prior to H2O2) or Chk2 inhibitor (CCT 241533, 3 nM for 2 h prior to H2O2).
(E and F) Representative Western blot analysis as in (C), on cells depleted of either Chk1 (E) or Chk2 (F) using siRNA. Phosphorylation of Sp1 is still
detected after treatment with H2O2. (G) Same as in (C), but cells were treated with an ATR inhibitor (VE-821, 1 M for 2 h prior to H2O2) (H) Same as
in (E), but cells were treated with an ATR siRNA. (I) Same as in (C), but cells were treated with a DNA-PKcs inhibitor (DNA-PK Inhibitor III, 10 M
for 2 h prior to H2O2). (J) Same as in (E), but cells were treated with DNA-PKcs siRNA. Data information: In (A–J) either actin or tubulin was used as
loading control.
Electrophoretic mobility shift assays (EMSA)
Electrophoretic mobility shift assays (EMSAs) were carried
out essentially as in (20). AnXRCC1 promoter probe (−145
to −128 bp) was obtained by annealing a 5′-IRDye®800-
labeled oligonucleotide (5′-GTGTGGCGGAGGGAGGC
GGGGCTGGAGGAAACG-3′ (Integrated DNA Tech-
nologies)), with its complementary sequence. An Sp1
consensus probe (5′-ATTCGATCGGGGCGGGGCGAG
C-3′) was used as cold competitor in order to confirm bind-
ing specificity.
Flow cytometry
For flow cytometry analyses, cells were harvested by
trypsinization and apoptosis was measured using the
AnnexinV-FITC Apoptosis Detection kit (Abcam) as per
manufacturer’s instructions. Samples were acquired using
a Becton-Dickinson FACSCalibur™ instrument and data
analysis was carried out using either BD CellQuest Pro or
FlowJo.
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Figure 2. Phosphorylation of Sp1 at Ser101 correlates with the amount
of DNA damage. (A) Representative Western blot analysis on TIG-1 cells
showing dose-dependent induction of ATM phosphorylation at Ser1981
and Sp1 phosphorylation upon treatment with H2O2 (50–100–200 M, 1
h) and release for either 0 or 24 h. Actin was used as loading control. (B)
Quantification of H2AX foci in TIG-1 cells treated as in (A). Foci were
scored using high-throughput microscopy. At least 500 cells/condition
were analyzed. The histogram reports the foci distribution as mean ± SD
from three independent experiments and confirms persistency of DNA
double strand breaks at the highest H2O2 dose 24 h after treatment *P
< 0.05; **P < 0.01.
Statistical analyses
Statistical analyses were performed with the two-tailed Stu-
dent’s t-test using either Microsoft Excel or SPSS (IBM).
Sample size is indicated for each experiment.
RESULTS
Direct phosphorylation of Sp1 at serine 101 by ATM in re-
sponse to DNA damage
Although a number of studies have demonstrated that Sp1
phosphorylation at Ser101 depends on ATM (13–15), it is
not clear whether Sp1 phosphorylation is accomplished by
ATM itself or can also bemediated by otherATM-activated
kinases. In order to unequivocally demonstrate that ATM is
responsible for direct phosphorylation of Sp1 at Ser101 we
employed an in vitro kinase assay using purified proteins.
Co-incubation of active recombinant ATM and recombi-
nant purified Sp1 showed that Sp1 is robustly phosphory-
lated by ATM at Ser101 (Figure 1A). Importantly, an Sp1
mutant in which Ser101 was changed into alanine (S101A)
could not be phosphorylated in vitro (Figure 1A), confirm-
ing the specificity of the antibody used in this study. Fur-
thermore, when the phosphorylation reaction was probed
with an antibody specific to the phospho-ATM/ATR sub-
strate motif (pS/pT QG), the Sp1 S101A mutant did not
show any phosphorylation (Figure 1B), suggesting that
Ser101 is the major site phosphorylated by ATM under
these conditions. Consistent with previous findings (14,15),
Sp1 phosphorylation was readily induced by H2O2 treat-
ment in normal human fibroblasts (Figure 1C). Modifica-
tion of Sp1 was prevented by inhibition of ATM kinase ac-
tivity (Figure 1C), confirming that Ser101 could be mod-
ified by either ATM or by another kinase downstream to
ATM in vivo. Using specific kinase inhibitors we demon-
strated that Sp1 phosphorylation at Ser101 was not depen-
dent on either Chk1 or Chk2 (Figure 1D) activity. These
observations were also substantiated by siRNA-mediated
knockdown of either Chk1 (Figure 1E) or Chk2 (Figure
1F), leading us to conclude that these kinases are not in-
volved in Sp1 phosphorylation at Ser101 in response to
DNA damage. Additionally, we checked if this phospho-
rylation was dependent on other members of the phos-
phatidylinositol 3-kinase family involved in the DNA dam-
age response (DDR), namely ATR and DNA-dependent
protein kinase catalytic subunit (DNA-PKcs).NeitherATR
inhibition (Figure 1G), nor siRNA-mediated knockdown
(Figure 1H) abrogated Ser101 phosphorylation upon treat-
ment with H2O2. Similarly, neither inhibition (Figure 1I),
nor siRNA-mediated knockdown of DNA-PKcs (Figure
1J) led to a loss of Ser101 phosphorylation, indicating that
Ser101 phosphorylation was not dependent on either ATR
or DNA-PKcs. These data demonstrate that, in response to
DNA damage, ATM is the major kinase responsible for di-
rect Sp1 phosphorylation at Ser101.
Unrepaired DNA strand breaks promote phosphorylation-
dependent degradation of Sp1
Human fibroblasts challenged with H2O2 are known to ac-
tivate ATM in a dose-dependent manner (14) and this is ac-
companied by accumulation of Ser101-phosphorylated Sp1
(Figure 2A).We observe here a striking correlation between
ATM activation, the Sp1 phosphorylation pattern and the
amount of DNA double strand breaks arising after a short
H2O2 treatment, as measured by scoring H2AX foci (Fig-
ure 2B). Notably, dose-dependent Sp1 phosphorylation ob-
served immediately after H2O2 treatment (Figure 2A, left-
hand side) correlated with the amount of DNA double
strand breaks generated (Figure 2B, left-hand side). Phos-
phorylation persisted 24 h after treatment (Figure 2A, right-
hand side) as a consequence of unrepaired DNA strand
breaks produced at the highestH2O2 dose tested (Figure 2B,
right-hand side). Consistent with this, other DNA strand-
break inducing agents such as topoisomerase I inhibitor
camptothecin and radiomimetic zeocin were also able to
trigger robust phosphorylation of Sp1 after a brief treat-
ment (Figure 3A and B).
The functional consequences of Sp1 phosphorylation are
poorly understood. To address this gap in our knowledge
we investigated the fate of phosphorylated Sp1 after per-
sistent DNA damage induced by prolonged exposure of
cells to H2O2 or zeocin. Interestingly, we observed a time-
dependent reduction of both phosphorylated and total Sp1
(Figure 3C and D), suggesting that Sp1 phosphorylation at
serine 101 may trigger destabilization of the protein. Fur-
thermore, cycloheximide treatment demonstrated reduced
Sp1 half-life after treatment with zeocin (Figure 3E and F).
In addition, inhibition of proteasome activity by MG132
prevented zeocin-induced Sp1 depletion suggesting persis-
tent DNA damage may negatively affect Sp1 stability (Fig-
ure 3G and H). In order to demonstrate that ATM kinase
activity is ultimately responsible for the modulation of Sp1
protein levels, we incubated cells with zeocin in the presence
of an ATM inhibitor. Inhibition of ATM kinase activity
prevented Sp1 downregulation induced by zeocin (Figure
3I), suggesting that DNA damage leads to ATM-dependent
phosphorylation of Sp1, followed by proteasomal degrada-
tion of the transcription factor.
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Figure 3. Unrepaired DNA strand breaks promote phosphorylation-dependent degradation of Sp1. (A and B) Representative Western blot analysis on
TIG-1 cells treatedwith camptothecin (10M,1h) (A), or zeocin (50g/ml, 2 h) (B) and showingATMandSp1 phosphorylation. (C andD) Representative
time-course on TIG-1 cells treated with H2O2 (200 M) (C), or zeocin (50 g/ml) (D) showing time-dependent ATM and Sp1 phosphorylation, followed
by degradation of Sp1. (E) Representative cycloheximide time-course on TIG-1 cells (50 g/ml) showing reduced Sp1 half-life upon zeocin treatment
(50 g/ml). (F) Densitometric quantification of the data presented in panel (E). Data are expressed as mean ± SD from three independent experiments
and confirm that Sp1 downregulation upon zeocin is due to increased protein turnover. (G) Representative Western blot analysis on TIG-1 cells showing
that Sp1 downregulation upon zeocin treatment (50 g/ml, 24 h) can be prevented by inhibition of proteasomal activity with MG132 (10 M, 6 h). (H)
Densitometric quantification of the data presented in panel (F). Data are expressed as mean ± SD from three independent experiments and confirm that
Sp1 downregulation upon zeocin is proteasome dependent. (I) RepresentativeWestern blot analysis on TIG-1 cells showing decreased amount of Sp1 upon
zeocin treatment (50 g/ml, 24 h) and recovery upon co-incubation with an ATM inhibitor (ATMi: KU60019, 10 M, 24 h). NS: not significant; *P <
0.05; **P < 0.01. Data information: In (A–I) actin was used as loading control.
Depletion of Sp1 impairs repair of endogenous DNA damage
via BER
Having established that in response to unrepaired DNA
strand breaks Sp1 undergoes ATM-dependent phosphory-
lation and degradation, we next sought to understand the
consequences of a reduction in Sp1 levels on the ability of
cells to repair DNA.
Alkaline comet assays showed that siRNA-mediated de-
pletion of Sp1 leads to an increased amount of endoge-
nously generated DNA strand breaks, even in the absence
of external stimuli (Figure 4A). As BER is the frontline
mechanism against endogenous DNA lesions, this pheno-
type pointed to a potential deficiency in this DNA repair
pathway. In order to test this, following Sp1 depletion we
measured the level of XRCC1 and DNA ligase III, key pro-
teins involved in the repair of endogenous SSBs. Consistent
with the observation of spontaneous accumulation of DNA
strand breaks (Figure 4A), we found that both proteins were
downregulated after Sp1 knockdown (Figure 4B–D; Sup-
plementary Figure S1). This resulted in a mild, but signifi-
cant deficiency in SSB repair in Sp1-depleted cells, as con-
Downloaded from https://academic.oup.com/nar/article-abstract/46/4/1834/4780164
by Chester Beatty Research Institute user
on 26 March 2018
Nucleic Acids Research, 2018, Vol. 46, No. 4 1839
Figure 4. Depletion of Sp1 leads to XRCC1 downregulation and impairs repair of endogenous DNA damage via BER. (A) Alkaline comet assay on TIG-1
cells 72 h after Sp1 depletion showing accumulation of DNA damage (N = 3). Relative DNA damage represents the percentage of DNA in the comet tail
normalized to the level in siCtrl cells. (B) Representative western blot analysis on cells treated as in (A). Sp1 depletion results in a reduction in XRCC1 and
LigIII protein levels. Actin was used as loading control. (C) Densitometric quantification of data presented in panel (B) confirming Sp1 depletion results
in a reduction in XRCC1 and LigIII protein levels (N= 4). (D) Representative micrographs on cells treated as in (A) showing downregulation of XRCC1
upon Sp1 knockdown. Scale bars 50 m. (E) In vitro assay measuring the nick ligation activity in Sp1- and XRCC1-depleted nuclear cell extracts. Sp1
downregulation impairs cellular nick ligation efficiency (N = 3). Data information: In (A, C and E), data are reported as mean ± SD from the indicated
number (N) of independent experiments *P < 0.05; ***P < 0.001.
firmed by in vitro ligation assays using nuclear cell extracts
and a nick-containing oligonucleotide duplex (Figure 4E).
Basal transcription of XRCC1 is modulated by Sp1
As depletion of Sp1 decreased XRCC1 protein levels (Fig-
ure 4B and C), we next tested whether Sp1 might be di-
rectly involved in the regulation of XRCC1 gene expres-
sion. Several lines of evidence were in support of this. First,
XRCC1 mRNA levels were reduced in both Sp1-depleted
cells (Figure 5A) and in cells treated with the Sp1 inhibitor
mithramycin A (Figure 5B). Secondly, using luciferase as-
says we measured the transcriptional activity of the ge-
nomic region spanning ∼4 kb upstream from the XRCC1
transcription start site. These experiments confirmed that
Sp1 modulates cellular activity of the XRCC1 promoter, as
depletion of Sp1 resulted in a significant reduction of the
reporter signal (Figure 5C). Additionally, ChIP assays al-
lowed us to confirm that Sp1 binds a region between −196
and −17 bp within the XRCC1 promoter (Figure 5D). Fi-
nally, using an oligonucleotide containing the putative Sp1
binding site in the XRCC1 promoter in electrophoretic mo-
bility shift assays (EMSAs) we detected Sp1 binding activity
in nuclear cell extracts (Figure 5E). EMSA experiments al-
lowed us to narrow the Sp1 binding site to a region between
−145 and −128 bp within the XRCC1 promoter. Impor-
tantly, under these experimental conditions Sp1 was likely
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Figure 5. Basal transcription ofXRCC1 is modulated by Sp1. (A) qPCR analysis showing reduction inXRCC1 transcription following Sp1 depletion (N=
4). (B) qPCRanalysis of XRCC1 transcript levels in TIG-1 cells treatedwith the Sp1 inhibitormithramycinA (MTM, 1M) for the indicated time. The level
of XRCC1 transcript decreases in a time-dependentmanner (N= 3). (C) Histogram showing reduction inXRCC1 promoter activity in cells depleted of Sp1,
as measured by luciferase assays (N= 4). (D) ChIP analysis on TIG-1 cells assessing ability of Sp1 to bind to theXRCC1 proximal promoter. Sp1 is enriched
at the XRCC1 promoter under basal conditions. Enrichment is lost upon Sp1 depletion. Results are expressed as fold enrichment relative to the unspecific
IgG (N = 3). (E) Representative EMSA measuring Sp1 binding activity to an XRCC1 proximal promoter probe. Left: TIG-1 cells were treated with
the indicated siRNA and nuclear extracts were used to assess Sp1 binding activity. The arrowhead indicates formation of a Sp1-containing protein–DNA
complex, which is lost upon Sp1 depletion. Comp: unlabeled Sp1 competitor sequence shows specificity of protein–DNA complex formation.Right: EMSA
using recombinant Sp1 protein and assessing its binding activity to the XRCC1 promoter probe. BSA was used as negative control. (F) Representative
EMSA measuring Sp1 binding activity to an XRCC1 proximal promoter probe in the presence of Sp1 inhibitor (MTM). Increasing concentrations of Sp1
inhibitor prevent formation of the protein–DNA complex. (G and H) qPCR analysis of XRCC1 transcript levels in TIG-1 cells treated with H2O2 (125
M, 72 h) (G) or zeocin (50 g/ml, 72 h) (H) in presence of an ATM inhibitor (ATMi: KU60019, 10 M 72 h), as indicated. Suppression of XRCC1
transcription upon DNA damage is ATM dependent (N = 3). Data information: In (A, B, C, D, G and H) data are reported as mean ± SD from the
indicated number (N) of independent experiments *P < 0.05; **P < 0.01; ***P < 0.001.
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the only factor able to bind the promoter probe, as siRNA-
mediated depletion of Sp1 resulted in a loss of binding ac-
tivity in cell extracts (Figure 5E, lane 3). Binding was also
affected by supplementing the nuclear extracts with the Sp1
inhibitor mithramycin A (Figure 5F). Moreover, Sp1 bind-
ing to the XRCC1 probe was completely abolished in the
presence of an Sp1 consensus competitor oligonucleotide
(Figure 5E, lane 4), while recombinant purified Sp1was suf-
ficient to achieve efficient binding of the probe (Figure 5E,
lane 6). Our findings strongly suggest that Sp1 modulates
basal transcription ofXRCC1 in normal human fibroblasts.
As we demonstrated that Sp1 degradation occurred in
an ATM-dependent manner in response to persistent unre-
paired DNA strand breaks (Figure 3I), we checked whether
this could affect XRCC1 expression. In line with our hy-
pothesis, XRCC1mRNA levels were significantly decreased
in cells treated with H2O2 or zeocin, and this could be
prevented by inhibition of ATM (Figure 5G and H). This
indicates that ATM-dependent Sp1 phosphorylation and
degradation modulate XRCC1 expression in response to
persistent DNA strand breaks.
We conclude that Sp1 is responsible for modulation
of XRCC1 gene expression and that activation of the
ATM/Sp1 axis in response to DNA damage has a negative
impact on XRCC1 transcription and BER efficiency.
The ATM/Sp1 cross-talk primes cells bearing persistent
DNA damage to apoptosis and accelerates their elimination
through NK cells
Our data demonstrate that persistent DNA lesions activate
ATM, which phosphorylates Sp1 and triggers a cellular re-
sponse that leads to suppression of DNA repair and fur-
ther DNA damage. We hypothesized that this somewhat
counterintuitive process could be a mechanism of ampli-
fication of a signal that allows cells with persistent DNA
strand breaks to be flagged for irreversible elimination. Al-
though previous studies indicated that ATM promotes pro-
grammed cell death (23,24) and that BER deficiency can
lead to apoptosis (4,25) the mechanism involved was not
clear.
In order to test our hypothesis we performed a series
of experiments. First, we examined cell morphology after
either Sp1 depletion, or zeocin treatment. We found that
both conditions led to noticeable changes in cell morphol-
ogy inlcuding an intensified cytoskeleton network, elon-
gated fusiform cellular shape and shrinkage of cellular ex-
tremities, as assessed by staining for the cytoskeleton pro-
tein -tubulin (Figure 6A). Importantly, this phenotype
was dependent on ATM activity, as ATM inhibition com-
pletely restored cellular morphology upon zeocin treat-
ment (Figure 6A). Altogether, these changes are consis-
tent with intense cellular stress, and are reminiscent of the
very early morphological profile observed in apoptotic fi-
broblasts (26). Following this conclusion, we investigated
whether cells expressing low levels of Sp1 could be in a pre-
apoptotic state. This idea was supported by qPCR analy-
ses that confirmed transcriptional upregulation of canoni-
cal pro-apoptotic genes including BAX and PUMA (BBC3)
in Sp1-depleted fibroblasts (Figure 6B and Supplementary
Figure S2A). Consistent with qPCR data, Sp1-depleted
cells expressed increased protein levels of BAX (Figure
6C). Importantly, ATM inhibition also effectively prevented
zeocin-induced upregulation of pro-apoptotic genes (Fig-
ure 6D and Supplementary Figure S2B), consistent with
a leading role for ATM in the signaling process. More-
over, Sp1-depleted cells showed greater sensitivity to apop-
tosis induced by the BH3-mimetic navitoclax (Figure 6E),
or pro-apoptotic agents such as staurosporine (Figure 6F)
and midostaurin (Figure 6G). In fact, cell treatment with
these agents induced full-blown apoptosis specifically in
Sp1-depleted cells, as demonstrated by caspase3/7 activa-
tion assays (Figure 6H–J), annexin V/propidium iodide
staining (Figure 7A and B) and cleavage of caspase 3 (Fig-
ure 7C). Furthermore, apoptosis regulator BAX underwent
cleavage specifically in Sp1-knockdown cells upon treat-
ment with navitoclax (Figure 7C). As BAX cleavage has
been proposed to boost apoptosis (27,28), we concluded
that cells expressing low levels of Sp1 are primed to apop-
tosis and that pro-apoptotic agents promptly trigger pro-
grammed cell death in these fibroblasts.
Our data suggest that, at the cellular level, downregula-
tion of Sp1 in response to persistent DNA strand breaks
primes cells to elimination. In a fully developed organism,
however, the innate immune response is tasked with the
elimination of genetically unstable host cells. In particu-
lar, NK cells have been shown to respond to oncogenic
stress and DNA damage, whereby upregulation of activat-
ing ligands in target cells has been proposed to be dependent
on ATM/ATR signaling (29,30). We reasoned that fibrob-
lasts bearing unrepaired DNA strand breaks and express-
ing lower amounts of Sp1 could be susceptible to recogni-
tion and elimination via NK cells. Consistent with our hy-
pothesis, co-culture experiments showed that Sp1-depleted
fibroblasts were indeed more susceptible to cell death in-
duced by NK cells (Figure 7D). Fibroblast hypersensitivity
to NK-mediated elimination was also observed when DNA
damage was induced using zeocin (Figure 7E) and crucially,
this phenotype was completely dependent on ATM’s kinase
activity (Figure 7E).
In conclusion, we have discovered a mechanism whereby
activation of ATM by persistent DNA strand breaks leads
to downregulation of transcription factor Sp1. This pro-
motes BER downregulation, further accumulation of DNA
damage and primes fibroblasts to apoptosis. These con-
ditions promote elimination of cells exposed to persistent
DNA damage by the innate immune system.
DISCUSSION
The inherent chemical instability of DNA, as well as intra-
and extra-cellular mutagens are the main sources of ge-
nomic DNA lesions, including DNA strand breaks (1).
BER is the major DNA repair pathway dealing with en-
dogenous DNA lesions and, under normal circumstances,
BER capacity curbs accumulation of SSBs, limiting spon-
taneous formation of DSBs. However, while accumulation
of DNA damage can occur in response to acute geno-
toxic stress, unrepaired DNA strand breaks can also be
present under pathophysiological circumstances where im-
paired BER is not able to promptly repair endogenous
DNA damage, leading to genetic instability (7,31–34). For
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Figure 6. Downregulation of Sp1 primes fibroblasts to apoptosis. (A) Representative micrographs from TIG-1 cells treated with either control siRNA
(siCtrl), Sp1-targeting siRNA (siSp1) or zeocin (50 g/ml, 72 h). An ATM inhibitor (ATMi: KU60019, 10 M72 h) was added where indicated. Both Sp1
depletion and zeocin treatments result in cytoskeleton contraction, as assessed by -tubulin staining (red). The phenotype is reversed by ATM inhibition.
Hoechst (blue) was used to stain nuclei. Scale bars: 50 m. (B) qPCR analysis assessing transcription of Bax in TIG-1 cells treated with the indicated
siRNA (N = 3). (C) Representative Western blot analysis on TIG-1 cells showing increased BAX protein levels upon Sp1 depletion. (D) qPCR analysis
assessing transcription of Bax in fibroblasts treated with zeocin (50 g/ml, 6 h). An ATM inhibitor (ATMi: KU60019, 10 M) was added where indicated.
Induction of Bax is completely prevented by ATM inhibition (N = 4). (E–G) Sensitivity of TIG-1 cells depleted of Sp1 to navitoclax (E), staurosporine
(F) or midostaurin (G). Cells were treated with increasing doses of the indicated drug 48 h after siRNA transfection. Cell viability was measured using
resazurin 48 h (E and G) or 24 h (F) after treatment (N = 3). (H–J) Caspase 3/7 activity assays showing increased caspase activity in cells treated with
navitoclax (2 M, 48 h) (H), staurosporine (125 nM, 24 h) (I) or midostaurin (8 M, 48 h) upon Sp1-depletion (J). Bars report the fold change in caspase
activity, normalized to drug-treated siCtrl cells (N = 4). Data information: In (B–I) data are reported as mean ± SD from the indicated number (N) of
independent experiments *P< 0.05; **P< 0.01; ***P< 0.001. In (C) actin was used as loading control and densitometric quantification is reported below
the blot.
this reason, control mechanisms must be in place to pro-
mote elimination of cells harboring unrepairedDNA strand
breaks to ultimately prevent genomic instability and finally
malignant transformation.
The main question addressed by this study is what are
the molecular mechanisms that detect cells deficient in the
repair of endogenous DNA lesions and direct them towards
elimination?
We propose a model whereby downregulation of tran-
scription factor Sp1 in response to a signal radiating from
ATM contributes to the elimination of potentially pre-
cancerous cells harboring persistent DNAdamage.We note
that phosphorylation of ATM, and the phosphorylated
form of transcription factor Sp1, are barely detectable un-
der unstressed conditions (Figures 1, 2 and 3). At this stage,
basal transcription of the XRCC1 gene, and consequently
BER capacity, are clearly sufficient to maintain genomic
stability (Figure 8, left). However, in response to accumu-
lation of DNA strand breaks, ATM phosphorylates and
destabilizes transcription factor Sp1. In turn, this leads to
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Figure 7. Downregulation of Sp1 primes fibroblasts to apoptosis and elimination by NK cells. (A and B) Apoptosis in cells depleted of Sp1 upon treatment
with navitoclax. Cells were transfected with the indicated siRNA and treated with either DMSO (Veh) or navitoclax (Nav: 2M, 48 h) before Annexin V/PI
staining and FACS analysis (N = 4). A representative density plot showing increased early- and late-apoptotic cells (bottom right and top right quadrant,
respectively) is shown (B). (C) Representative Western blot analysis on cells treated as in (A) and showing cleaved caspase 3 and BAX in cells depleted
of Sp1 upon treatment with navitoclax (Nav). Quantification of total BAX is reported at the bottom of the gel; actin was used as loading control. (D)
Survival of TIG-1 fibroblasts upon incubation with NK cells. TIG-1 cells were treated with the indicated siRNA for 48 h before co-culture with NK cells
at the indicated ratio for a further 24 h. Cell viability was measured using resazurin. Data show dose-response curves representative of three independent
biological replicates. (E) Survival of TIG-1 fibroblasts upon incubation with NK cells. Cells were treated as indicated for 48 h, followed by co-incubation
with NK cells for further 14 h. Cell viability was measured using resazurin. Data show dose-response curves representative of three independent biological
replicates. Data information: In (A, D and E) data are reported as mean ± SD from the indicated number (N) of independent experiments *P < 0.05; **P
< 0.01; ***P < 0.001.
downregulation of XRCC1 transcription, decreased levels
of DNA ligase III and reduction in BER capacity. This
mechanism leads to accumulation of further DNA strand
breaks, resulting in a self-accelerating cycle (Figure 8, right).
This kind of scenario may represent a response to exces-
sive acute DNA damage, or to BER failure. In both cases
this will result in cell elimination either through apoptosis
or by components of the innate immune system. We believe
this represents a protective pro-survival mechanism to en-
sure the removal of cells with persistent unrepaired DNA
strand breaks.
Sp1 Ser101 phosphorylation in response to DNA dam-
age has been previously described in a number of studies
(13–15) although the specific trigger for Ser101 phosphory-
lation was not known. We show that this occurs directly via
ATM (Figure 1) in response to genome-threatening lesions
including both SSBs and DSBs (7,8). These findings led us
to hypothesise that DNA strand breaks in general are likely
the major trigger for Ser101 phosphorylation. However, the
inherent cross-talk between DDR kinases, and complex na-
ture of DNA damage induced by agents such as zeocin
means that we cannot exclude the involvement of other trig-
gers, including stalled replication forks, or a role for other
kinases in specific cellular contexts. Although the occur-
rence of Ser101 phosphorylation is well-documented (13–
15), its precise function has remained elusive. This study
addresses this gap in our knowledge, linking Ser101 phos-
phorylationwith Sp1 protein stability. Our data suggest that
Sp1 destabilization occurs via the proteasome (Figure 3F).
However, the exact mechanism is unclear, such as whether
Sp1 degradation is linked to ubiquitylation; we were un-
able to detect ubiquitylated Sp1 protein after DNA dam-
age (data not shown). E3 ligase RNF4 and TrCP, a com-
ponent of SCF ubiquitin ligase complexes have previously
been linked to Sp1 degradation (35,36). However, our at-
tempts to prevent Sp1 downregulation after persistentDNA
damage by targeting either RNF4 or TrCP with siRNAs
were unsuccessful (data not shown). Moreover, type, dose
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Figure 8. Graphical summary of the model supported by this study. Left:
in a normal cell, endogenous DNA damage is kept under control by DNA
repair mechanisms. Low ATM activity ensures stable Sp1 protein levels,
promoting efficient expression of DNA repair genes and low levels of cell
death.Right: genomically stressed cells can arise under conditions of exces-
sive exogenous DNA damage, or DNA repair deficiency. This leads to per-
sistent DNA strand breaks and ATM activation, which triggers Sp1 phos-
phorylation and degradation. In this situation the cellular load of DNA
strand breaks is aggravated by decreased expression of DNA repair genes,
leading to further ATM phosphorylation, activation of a pro-apoptotic
cascade and death through apoptosis or cell elimination.
and duration of DNA damage are likely important consid-
erations for determining the kinetics of the Sp1 response.
Given that Sp1 destabilization in TIG-1 normal human
fibroblasts did not occur immediately after genotoxic in-
sult, but only when DNA damage persisted (Figure 3A–
D), this suggests dependency on the cellular load of unre-
pairedDNA strand breaks. Decreased Sp1 protein levels af-
ter H2O2 treatment has previously been observed in HeLa
cells (37). However, this occurred using a shorter but higher
dose of H2O2, thus supporting the hypothesis that the cel-
lular DNA damage load is crucial for determining Sp1 sta-
bility. Moreover, the differential response time between fi-
broblasts and HeLa cells suggests that cell type is also an
important determinant of Sp1 stability after DNA damage.
Therefore, further study to fully elucidate the mechanism
behind Sp1 degradation is warranted.
We demonstrated that loss of Sp1 is associated with in-
creased sensitivity to cell elimination (Figure 7). Immune
surveillance in whole organisms by components of the in-
nate immune system including NK cells, constitutes an
important defense against tumorigenesis by eliminating
stressed, damaged or tumorigenic cells. Recognition of such
cells is proposed to occur through upregulation of cytotoxic
NK cell receptor NKG2D (NK group 2, member D) lig-
ands which include the MIC and ULPBP protein families
(29). Interestingly, expression of some activating NKG2D
ligands is proposed to depend on the ATM/ATR signal-
ing axis (29,30,38). It is therefore tempting to speculate
that NK cells recognize and eliminate fibroblasts harboring
persistent unrepaired DNA strand breaks through ATM-
dependent upregulation of NKG2D ligands.
The consequences of DNA damage are inexorably linked
to the severity of the lesion. It remains unknown, how-
ever, how cells transition between pro-survival and pro-
death responses as a consequence of unrepairable DNA le-
sions. Several lines of evidence indicate that the ATM ki-
nase performs a key role in this process (6); multiple stud-
ies highlight the involvement of ATM in apoptosis in re-
sponse to DNA damage (10,11,39) and emerging evidence
has linked ATM with promoting immune surveillance (29).
Our study supports a role for ATM in the pro-survival/pro-
death decision-making process through ATM-dependent
destabilization of Sp1. Of note, ATM has been suggested
to undergo selective pressure for inactivation in cancer (40),
while loss of ATM function correlates with the occurrence
of malignancies (41–43); this could explain how genetically
unstable cells might escape this control mechanism, leading
to cancer emergence.
While we demonstrate that this protective mechanism ex-
ists in normal untransformed fibroblasts, it is of interest to
understand whether it remains active in cancer cells, par-
ticularly where ATM function is not impaired. It raises the
question whether it is possible to target this mechanism us-
ing chemotherapeutic drugs to induce elimination of can-
cerous cells. Moreover, given the sensitivity to apoptosis
observed in Sp1-depleted cells, it is tempting to speculate
whether low-Sp1 expressing tumors might show sensitivity
to pro-apoptotic agents. Clearly, the potential exploitation
of this system requires further study.
Moreover, the existence of a similar mechanism involv-
ing downregulation of DNA repair to enable selective cell
killing has recently been proposed (44). In their study,
Ponath and Kaina suggested that monocytes expressing
lower levels of BER components could be eliminated by
their differentiated counterpart, macrophages, when these
cells generate a reactive oxygen species burst during the in-
flammatory response (44).
In summary, we believe that the molecular mechanism
we propose could explain how physiological populations of
healthy cells are maintained in an organism, by detecting
and eliminating cells with DNA repair defects.
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